Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.
Open | $154.590 |
Close | $157.060 |
Volume / Avg. | 759.238K / 539.410K |
Day Range | 152.190 - 159.350 |
52 Wk Range | 110.450 - 211.130 |
Market Cap | $8.770B |
P/E Ratio | 217.446 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 10% |
Days to Cover | 13.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Repligen (NASDAQ: RGEN) through any online brokerage.
Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for Repligen (NASDAQ: RGEN) was reported by Stifel on Thursday, February 22, 2024. The analyst firm set a price target for 207.00 expecting RGEN to rise to within 12 months (a possible 31.80% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Repligen (NASDAQ: RGEN) is $157.06 last updated April 18, 2024 at 4:06 PM EDT.
There are no upcoming dividends for Repligen.
Repligen’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Repligen.
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.